GlassScriptPhysician profile
Vikram S Wadhwa
NPI 1417134040
$3,531.70
in general payments reported to CMS, 2019-2025
8 companies · $823 in 2025
The $823 reported for 2025 was more than what 83% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2021: $428 · 2022: $23.69 · 2023: $342 · 2024: $1,268 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,432.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,142.26 | 2021-2025 | Trevo, Target, Axs Vecta 71 |
| Penumbra, INC. | $740.66 | 2023-2025 | Red 72, Penumbra System, Penumbra Coil 400 |
| Medtronic USA, INC. | $647.39 | 2019 | |
| Imperative Care, INC | $297.91 | 2024-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom 88 Large Distal Platform Support |
| Depuy Synthes Sales INC. | $214.64 | 2023-2024 | Embotrap |
| Rapid Medical LTD | $205.33 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Medtronic, INC. | $174.05 | 2021-2025 | Concertotm, Solitaire X |
| Route 92 Medical, INC. | $109.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Wadhwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.